About Us: Company at a Glance

Our Mission

To provide our customers with the finest, high-quality service in the highly  regulated clinical biomarker industry.

Our Vision

To predict the response to the high value medicines of tomorrow.


Founded in Kassel, Germany in 2005 by Dr. Thomas Henkel, Prof. Josef Rüschoff and Prof. Reinhard Büttner.


80 and growing in three divisions.


+ 16 senior consulting clinical pathologists in Kassel, Cologne and Göttingen, Germany


Pathologie Nordhessen, Kassel, Germany
University of Cologne, Cologne, Germany
University of Göttingen, Göttingen, Germany

Quality Assurance

Audited annually since 2005 by FDA, Pharma PDQA and Biotech QA

Turn-around Time

As low as 24 hours for clinical tissue biomarker analysis

Companion Diagnostics

(a) The first co-development of companion diagnostics for Roche COBAS and B-Raf together with Genentech/Roche drug Zelboraf in a prospective clinical trial.
(b) HercepTest™ for Herceptin™ for Gastric Cancer in a prospective clinical trial.


With more than 30 industry leading pharmaceutical, biotech and diagnostic companies in Europe and United States

Reference Laboratory

For Europe, Latin America and the Middle East.


High impact publications of supported trials in The Lancet, New England Journal of Medicine, Journal of Clinical Oncology etc.


Prof. Dr. med. Josef Rüschoff: International Herceptin Pathology Advisory Board.
Prof. Dr. med. Reinhard Büttner: Member of the German Academy for Sciences.

Global Clinical Trials

Reference laboratory for global clinical trials.
Analysis of more than 60,000 patients in100 clinical trials pertaining to breast, gastric, lung and skin cancers in more than 1000 sites worldwide